Login / Signup
Is a BTKi or BCL2i preferable for first "novel" therapy in CLL? The case for BTKis.
Elizabeth A Brem
Susan O'Brien
Published in:
Blood advances (2022)
Keyphrases
</>
chronic lymphocytic leukemia
smoking cessation
replacement therapy